| Literature DB >> 35777652 |
Kirk H Waibel1, Tamara T Perry2.
Abstract
Secondary to the coronavirus disease 2019 pandemic, telehealth quickly peaked as the dominant health care modality and its use still remains high. Although allergists and health care systems adapted quickly to adopt telehealth, its increased use has both highlighted its benefits for patients and allergists and demonstrated known concerns with delivering allergy specialty care to rural and regional patient populations. With increased concentration of both patients and allergists in urban areas, the ability to provide allergy specialty care to the rural and remote population continues to remain a challenge despite the advantages leveraged through telehealth. Herein, we review aspects specific to the rural patient population, tele-allergy outcomes with these patient cohorts, and efforts, both past and present, taken at different levels within the allergy community to promote our specialty through specific telehealth modalities to address and engage the rural and regional patient.Entities:
Keywords: Allergy; Regional; Rural; School; Telehealth; Telemedicine
Mesh:
Year: 2022 PMID: 35777652 PMCID: PMC9280446 DOI: 10.1016/j.jaip.2022.06.025
Source DB: PubMed Journal: J Allergy Clin Immunol Pract
Figure 1Telehealth scenarios for allergists and patients. Conducting a telehealth visit has 3 main aspects: the distant site, the modality used, and the originating site. (A) The distant site is where the allergist is located. (B) The modality is the platform used by the health care provider and the patient to communicate, while the (C) originating site is where the patient is located. Additional descriptions of each modality can be found in this article’s Online Repository at www.jaci-inpractice.org.
Advantages, disadvantages, and unintended consequences of a regional telehealth platform
| Advantages |
Expansion of connected health to more population groups Co-location of required support staff (ie, information technology, credentialing, schedulers, nurse call center, etc) Allergists embedded within larger organizational structure Improved position to adapt to ever-changing regulations Centralized efforts and strategy Improved communication between regional medical center specialties and originating site locations Increased involvement with Graduate Medical Education and telehealth training Focused on “value” aspects of telehealth (eg, emergency department visits, readmission rates, drug allergy evaluation, and reduced carbon footprint) Reduced time from referral to specialty visit |
| Disadvantages |
Significant start-up costs (eg, staff, peripheral carts, and peripheral medical devices) Success requires strong C-suite support and specialty “champions” Initial efforts may focus on one specialty over another Provider reluctancy to use telehealth (“late adopters”) Initial efforts can wither without sustained financial investment and staffing Underuse of originating site(s) without dedicated full-time equivalent assets |
| Unintended consequences |
Information technology aspects (eg, patient portals and internet connectivity) may be a barrier for patients with limited connectivity Telehealth support assets may not increase with increased provider visits Increased telehealth appointments may result in increased need for “in-person” visits, which may be a preexisting geographic barrier for rural and remote patients Increased telehealth may reduce clinical or laboratory visits with local community providers Increased work for health care and information technology teams at originating sites |
Reportable telehealth metrics
| Metric | Outcome |
|---|---|
| No. of visits | In-person, tele-allergy |
| Patient characteristics | Age, sex, ethnicity, socioeconomic status, insurance type, etc |
| Type of appointment | New vs follow-up |
| Modality of patient communication | In-person, telephone, synchronous without facilitator, mHealth, telementoring, etc |
| Originating site (patient location) | Home, clinic, school, medical center, etc |
| Population density at patient location | Urban, suburban, rural |
| Distance from allergist | miles, km |
| Time “saved” by using telehealth | Work and/or school days “saved” |
| “Green” effect | Environmental implications if driving not required (eg, CO2 emissions, etc) |
| % follow-up recommended | Percentage |
| % follow-up completed | Percentage |
| Standardized outcomes | ACT, UCT, UAS7, SNOT, ED visits, hospitalizations, QOL surveys, etc |
| Allergy visits conducted via telehealth | Percentage |
| Telehealth visits per service compared with overall hospital visits | Percentage |
| Patient satisfaction | Percentage satisfied/dissatisfied |
| Provider satisfaction | Percentage satisfied/dissatisfied |
| No. of patient engagements | Number (eg, telephone call, home visits, and school visits) |
| No. of originating sites | Number |
| No. of encounters per originating site | Number |
| wRVUs generated | Originating site; distant site |
| Specialty no-show rate | In-person vs telehealth |
| No. of days to first open appointment | In-person vs telehealth |
| Appointment availability | Weekday vs weekend; business hours vs “after hours” |
ACT, Asthma Control Test; ED, emergency department; QOL, quality of life; RVU, relative value unit; UAS7, Urticaria Activity Score 7; SNOT, Sino-Nasal Outcome Test; UCT, Urticaria Control Test.